Vice President, Strategic Program Direction
I am passionate about developing oncology drugs that are clinically practice-changing and improve the lives of cancer patients globally. As Vice President, Strategic Program Direction at Regeneron, I currently lead the bispecific antibody and co-stimulatory antibody development programs in B-cell Non-Hodgkin Lymphomas. I obtained my medical degree from the University of Manchester and trained in general surgery at Leeds University, UK. I also obtained an MBA from Cornell Johnson School of Business and a MS in Healthcare Leadership from Weill Cornell Graduate School of Medicine. I currently serve on the Board of Directors of Savor Health, a healthcare tech start-up utilizing an AI-based technology platform to provide personalized, clinically appropriate nutrition recommendations to cancer patients. During the COVID19 pandemic, I have helped to lead Mutual Aid efforts in my community by founding LICSupport.org, a volunteer-led organization supporting vulnerable residents shelter in place safely. I have a strong interest in developing long-term solutions that address social determinants of health and health inequity that really have underpinned the magnitude of the impact of COVID19 experienced in Queens. In my spare time, I enjoy afternoon tea, formula 1 motor racing, running, travel and all things creative.